Oscar Health, INC Form 4 insider transactions
NYSE
Oscar Health's Chief Legal Officer, Adam McAnaney, disposed of 1,845 shares of Class A Common Stock to cover tax obligations related to RSU vesting.
NYSE
Oscar Health's President of Technology & CTO, Mario Schlosser, disposed of 23,879 Class A common shares to cover tax withholding obligations related to RSU vesting.
NYSE
Oscar Health, Inc. Director David Plouffe acquired 1,368 deferred stock units on July 10, 2025, as compensation for his board service, bringing his total beneficial ownership to 3,102 units.
NYSE
Oscar Health, Inc. Director William Gassen acquired 1,215 deferred stock units on July 10, 2025, in lieu of cash compensation for his board service, increasing his beneficial ownership to 2,745 units.
NYSE
Oscar Health, Inc. Director Jeffery H. Boyd elected to receive 3,380 deferred stock units valued at $15.53 per unit in lieu of cash for board service, increasing his beneficial ownership.
NYSE
Oscar Health, Inc. Director Jeffery H. Boyd was granted 14,134 restricted stock units (RSUs) on June 4, 2025, increasing his beneficial ownership to 705,673 shares of Class A Common Stock.
NYSE
Oscar Health, Inc. Director Laura W. Lang was granted 14,134 Class A Common Stock Restricted Stock Units (RSUs) on June 4, 2025, increasing her beneficial ownership to 74,365 shares.
NYSE
Oscar Health, Inc. Director David Plouffe has reported the acquisition of 14,134 Class A Common Stock restricted stock units (RSUs) on June 4, 2025, increasing his total beneficial ownership to 128,646 shares.
NYSE
Form 4: Oscar Health Director Sid Sankaran Receives Significant RSU Grant, Boosting Direct Equity Holdings
Oscar Health, Inc. Director Sid Sankaran has acquired 14,134 Class A Common Stock shares through a restricted stock unit (RSU) grant, increasing his direct beneficial ownership.
NYSE
Oscar Health, Inc. Director Vanessa Ames Wittman was granted 14,134 Class A Common Stock restricted stock units (RSUs) on June 4, 2025, increasing her direct beneficial ownership to 128,646 shares.
NYSE
Oscar Health, Inc. Director William Gassen was granted 14,134 restricted stock units (RSUs) on June 4, 2025, increasing his total beneficial ownership to 74,365 Class A Common Stock shares.
NYSE
Janet Liang, President of Oscar Insurance, disposed of 7,196 shares of Oscar Health Class A Common Stock at $13.8 per share to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
Oscar Health's Chief Legal Officer, Adam McAnaney, reported the disposition of 1,847 shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
Oscar Health's President of Technology & CTO, Mario Schlosser, reported the disposition of 23,879 Class A Common Stock shares to cover tax withholdings from restricted stock unit vesting, while also correcting a previous filing regarding his total beneficial ownership.
NYSE
Oscar Health's Chief Financial Officer, Richard Scott Blackley, disposed of 28,185 shares of Class A Common Stock on June 2, 2025, to cover tax withholding obligations related to restricted stock unit vesting.
NYSE
Oscar Health's Chief Accounting Officer, Victoria Baltrus, reported the disposition of 6,265 Class A common shares to satisfy tax obligations related to restricted stock unit vesting.
NYSE
Director Elbert O. Robinson Jr. sold 25,000 shares of Oscar Health's Class A Common Stock at a weighted average price of $16.43 on May 12, 2025.
NYSE
Director David Plouffe received 1,734 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments for board service.
NYSE
Director William Gassen received 1,530 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments.
NYSE
Director Jeffery H. Boyd acquired 4,285 deferred stock units of Oscar Health, Inc. in lieu of cash retainer payments.
NYSE
Mark Bertolini, CEO of Oscar Health, reports the vesting of restricted stock units resulting in the issuance of Class A Common Stock.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc., reported the acquisition of 10,611 restricted stock units (RSUs) on March 5, 2025, according to a Form 4 filing with the SEC.
NYSE
Mario Schlosser, President of Technology & CTO at Oscar Health, reports the acquisition of restricted stock units and an adjustment to his holdings of Class A Common Stock.
NYSE
Form 4: Oscar Health CFO Richard Blackley Reports Acquisition of 103,426 Shares of Class A Common Stock
Richard Scott Blackley, CFO of Oscar Health, reports the acquisition of 103,426 shares of Class A Common Stock on March 5, 2025, bringing his total holdings to 1,432,520 shares.
NYSE
Janet Liang, President of Oscar Insurance, reported the vesting of restricted stock units in Oscar Health, Inc.
NYSE
Form 4: Oscar Health's Chief Legal Officer, Adam McAnaney, Reports Acquisition of Restricted Stock Units
Adam McAnaney, Chief Legal Officer of Oscar Health, Inc., reports the acquisition of restricted stock units (RSUs) and updates to his beneficial ownership of Class A Common Stock.
NYSE
Mario Schlosser, President of Technology & CTO of Oscar Health, Inc., disposed of shares to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Richard Scott Blackley, CFO of Oscar Health, Inc., disposed of 22,428 shares of Class A Common Stock on March 1, 2025, to cover tax withholding obligations related to vesting restricted stock units.
NYSE
Victoria Baltrus, Chief Accounting Officer of Oscar Health, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
NYSE
Adam McAnaney, Chief Legal Officer of Oscar Health, reports the acquisition of stock options and restricted stock units.